Answers are grounded in this paper and cite their sources.
Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double-blind cross-over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequency or severity of attacks of Raynaud's phenomenon.
No takes yet. Share an insight, caveat, or question.
RUSTIN et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: